OmniAb
Yahoo Finance • 2 months ago
OmniAb Q2 2025 slides: Partner growth accelerates despite revenue decline
OmniAb Inc. (NASDAQ:OABI) presented its second-quarter 2025 financial results and business update on August 6, revealing a company experiencing robust partner and program growth despite financial challenges. The antibody discovery platform... Full story
Yahoo Finance • last year
OmniAb Inc (OABI) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ...
Total Revenue: $7.6 million for Q2 2024, compared to $6.9 million in the prior year quarter. Service Revenue: Included an accelerated $1.3 million due to the discontinuation of the GSK small molecule ion channel program. R&D Expense: Relat... Full story
Yahoo Finance • 3 years ago
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
For investors, the stock market is always a game of risk and reward, and no segment exemplifies that better than the penny stocks. Defined as stocks trading at a price of less than $5, the pennies bring an ultra-low cost of entry to the ta... Full story
